ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,027 | -1.5% | 16,355 | +11.6% | 0.00% | 0.0% |
| Q2 2023 | $450,584 | -12.1% | 14,653 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $512,646 | -64.1% | 14,230 | -60.6% | 0.00% | -33.3% |
| Q4 2022 | $1,426,090 | +233.2% | 36,080 | +238.1% | 0.00% | +50.0% |
| Q3 2022 | $428,000 | -2.1% | 10,671 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $437,000 | +54.4% | 10,412 | +42.8% | 0.00% | +100.0% |
| Q1 2022 | $283,000 | -34.6% | 7,293 | -33.0% | 0.00% | -50.0% |
| Q4 2021 | $433,000 | +10.2% | 10,891 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $393,000 | -25.0% | 10,868 | -15.0% | 0.00% | 0.0% |
| Q2 2021 | $524,000 | -2.1% | 12,791 | +4.3% | 0.00% | 0.0% |
| Q1 2021 | $535,000 | +24.1% | 12,265 | +42.2% | 0.00% | 0.0% |
| Q4 2020 | $431,000 | – | 8,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |